Danaher Shares Outstanding 2012-2026 | DHR

Danaher shares outstanding history from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Danaher shares outstanding for the quarter ending March 31, 2026 were 0.711B, a 1.33% decline year-over-year.
  • Danaher 2025 shares outstanding were 0.716B, a 2.86% decline from 2024.
  • Danaher 2024 shares outstanding were 0.737B, a 0.79% decline from 2023.
  • Danaher 2023 shares outstanding were 0.743B, a 0.81% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Danaher Annual Shares Outstanding
(Millions of Shares)
2025 716
2024 737
2023 743
2022 737
2021 737
2020 719
2019 726
2018 710
2017 706
2016 700
2015 709
2014 716
2013 711
2012 713
2011 701
Danaher Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 711
2025-12-31 711
2025-09-30 714
2025-06-30 719
2025-03-31 721
2024-12-31 737
2024-09-30 729
2024-06-30 742
2024-03-31 749
2023-12-31 743
2023-09-30 746
2023-06-30 745
2023-03-31 737
2022-12-31 737
2022-09-30 737
2022-06-30 736
2022-03-31 738
2021-12-31 737
2021-09-30 727
2021-06-30 736
2021-03-31 735
2020-12-31 719
2020-09-30 724
2020-06-30 718
2020-03-31 708
2019-12-31 726
2019-09-30 729
2019-06-30 728
2019-03-31 719
2018-12-31 710
2018-09-30 711
2018-06-30 710
2018-03-31 710
2017-12-31 706
2017-09-30 706
2017-06-30 705
2017-03-31 706
2016-12-31 700
2016-09-30 701
2016-06-30 699
2016-03-31 697
2015-12-31 709
2015-09-30 699
2015-06-30 720
2015-03-31 719
2014-12-31 718
2014-09-30 716
2014-06-30 716
2014-03-31 715
2013-12-31 714
2013-09-30 712
2013-06-30 710
2013-03-31 708
2012-12-31 713
2012-09-30 714
2012-06-30 715
2012-03-31 714
2011-12-31 701
2011-09-30 710
2011-06-30 695
Sector Industry Market Cap Revenue
Medical Medical Services $134.187B $24.568B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
HCA Healthcare (HCA) United States $110.772B 17.53
CVS Health (CVS) United States $101.670B 11.75
Elevance Health (ELV) United States $68.432B 10.33
Cencora (COR) United States $62.409B 19.63
Natera (NTRA) United States $27.358B 0.00
Labcorp Holdings (LH) United States $21.501B 15.87
DiDi Global (DIDIY) China $18.026B 15.96
Viatris (VTRS) United States $15.685B 5.71
EUROFINS SCIENT (ERFSF) Luxembourg $14.535B 0.00
Medpace Holdings (MEDP) United States $14.094B 32.26
BioMerieux (BMXMF) France $12.476B 0.00
Solventum (SOLV) United States $11.408B 10.78
Revvity (RVTY) United States $10.039B 17.71
BrightSpring Health Services (BTSG) United States $8.774B 43.59
Charles River Laboratories (CRL) United States $8.667B 17.09
ICON (ICLR) Ireland $8.626B 8.56
CochLear (CHEOY) Australia $8.030B 0.00
Sonic Healthcare (SKHHY) Australia $6.905B 0.00
HealthEquity (HQY) United States $6.586B 23.20
Bausch + Lomb (BLCO) Canada $5.877B 32.98
GETINGE (GNGBY) Sweden $5.626B 17.96
Avantor (AVTR) United States $5.388B 8.68
PACS (PACS) United States $5.304B 27.44
Caris Life Sciences,�Inc (CAI) United States $5.101B 0.00
Sotera Health (SHC) United States $4.380B 19.95
Alignment Healthcare (ALHC) United States $4.188B 0.00
Concentras Parent (CON) United States $2.818B 16.12
Organon (OGN) United States $2.299B 2.57
Amplifon S.p.A (AMFPF) Italy $2.275B 13.27
Pediatrix Medical (MD) United States $1.782B 11.11
Establishment Labs Holdings (ESTA) United States $1.765B 0.00
GeneDx Holdings (WGS) United States $1.746B 42.28
Surgery Partners (SGRY) United States $1.671B 41.65
Sonida Senior Living (SNDA) United States $1.544B 0.00
Ardent Health (ARDT) United States $1.345B 5.70
Progyny (PGNY) United States $1.277B 25.08
Ryman Healthcare (RYHTY) New Zealand $1.240B 0.00
InnovAge Holding (INNV) United States $1.113B 164.00
Teladoc Health (TDOC) United States $0.920B 0.00
CareDx (CDNA) United States $0.822B 0.00
GoodRx Holdings (GDRX) United States $0.750B 12.17
Enhabit (EHAB) United States $0.709B 25.89
Nutex Health (NUTX) United States $0.704B 11.25
Omada Health (OMDA) United States $0.672B 0.00
QDM (QDMI) Hong Kong, SAR China $0.604B 99.85
COMPASS Pathways (CMPS) United Kingdom $0.531B 0.00
Embecta (EMBC) United States $0.524B 2.92
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
CryoPort (CYRX) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.435B 4.70
SBC Medicals (SBC) United States $0.426B 8.47
Forward Industries (FWDI) United States $0.375B 0.00
Strata Critical Medical (SRTA) United States $0.349B 0.00
Agilon Health (AGL) United States $0.316B 0.00
Shoulder Innovations (SI) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.304B 0.00
So-Young (SY) China $0.262B 0.00
LifeMD (LFMD) United States $0.166B 0.00
Biodesix (BDSX) United States $0.133B 0.00
Beauty Health (SKIN) United States $0.115B 0.00
Ascend Wellness Holdings (AAWH) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.080B 0.00
Sera Prognostics (SERA) United States $0.077B 0.00
DocGo (DCGO) United States $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Pomdoctor - (POM) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.026B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.015B 0.00
Basel Medical Group (BMGL) Singapore $0.011B 0.00
Lifeward (LFWD) United States $0.010B 0.00
XWELL (XWEL) United States $0.009B 0.00
Aclarion (ACON) United States $0.007B 0.00
Synergy CHC (SNYR) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Co-Diagnostics (CODX) United States $0.005B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00